DDAVP featured on the Cardiff Haemophilia centre returns for the first time, and there was no record of its use to any significant extent in 1983. There was a reduction in the use of cryoprecipitate for the treatment of patients with Haemophilia A, with the main treatment product being NHS concentrates (809,972 units) and commercial concentrates (1,051,422 units).